Travatan

DRUG6 trials

Sponsors

Alcon Research, Hermann Eye Center, The University of Hong Kong

Conditions

GlaucomaGlaucoma, Open-angleIntraocular PressureOcular HypertensionOpen Angle GlaucomaOpen-angle GlaucomaPseudoexfoliation Syndrome

Phase 2

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

CompletedNCT00637130

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-10-31Updated: 2012-12-06

Phase 3

A Long-term Safety Study of Once-daily Travatan

CompletedNCT00051168

Alcon ResearchGlaucoma, Open-angle, Ocular Hypertension

Start: 2006-01-31Updated: 2011-10-07

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

TerminatedNCT00767494

Alcon ResearchGlaucoma, Ocular Hypertension

Start: 2008-10-31End: 2009-02-28Updated: 2012-09-19

Phase 4

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

TerminatedNCT00471068

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-03-31Updated: 2012-04-11

Unknown Phase

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

CompletedNCT00121147

Hermann Eye CenterOcular Hypertension, Open Angle Glaucoma, Pseudoexfoliation Syndrome

Start: 2003-09-30End: 2005-10-31Target: 200Updated: 2006-02-24

Interval Intraocular Pressure in Intravitreal Injection Study

CompletedNCT04868175

The University of Hong KongGlaucoma, Intraocular Pressure

Start: 2019-10-01End: 2021-04-01Updated: 2021-04-30